Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-cjp7w Total loading time: 0 Render date: 2024-06-15T13:59:58.433Z Has data issue: false hasContentIssue false

13 - When ARIA Is More than an Operatic Solo

Published online by Cambridge University Press:  12 November 2022

Daniel Gibbs
Affiliation:
Emeritus of Oregon Health and Science University
Teresa H. Barker
Affiliation:
Freelance journalist and author of scientific non-fiction
Get access

Summary

Lois and I joked occasionally about my faltering memory when I’d read some riveting novel and chat about it in great detail with her over dinner, then have a hard time remembering it a week later. But one day I woke up unable to read simple words without spelling them out, and there was nothing amusing about it. We were stunned. Everything had been going so well.

Two months earlier, at the end of September 2017, I had the first monthly infusion of the extended trial. Now I knew I was getting aducanu-mab, and had been pleased that for the next month I had no side effects. During the next infusion a month later, the only noticeable side effect was that I experienced a new phantosmia, the illusory smell experiences I’d had occasionally for the past ten years. This one smelled like orange-scented soap and lasted about thirty minutes.

Type
Chapter
Information
A Tattoo on my Brain
A Neurologist's Personal Battle against Alzheimer's Disease
, pp. 91 - 101
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chapter-references

Viswanathan, A, Greenberg, SM. Cerebral amyloid angiopathy in the elderly. Annals of Neurology 2011; 70:871880 (public access version available at www.ncbi.nlm.nih.gov/pmc/articles/PMC4004372).Google Scholar
Liu, E, Wang, D, Sperling, R, et al. Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab. Neurology 2018; 90:e877e886; https://doi.org/10.1212/WNL.0000000000005060.Google Scholar
Knopman, D.S. Sifting through a failed Alzheimer trial: what biomarkers tell us about what happened. Neurology 2018; 90:447448; https://doi.org/10.1212/WNL.0000000000005073.Google Scholar
VandeVrede, L, Gibbs, DM, Koestler, M, et al. Symptomatic amyloid-related imaging abnormalities in an ApoE-ε4/ε4 patient treated with aducanumab. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 2020; 12:e12101; https://doi.org/10.1002/dad2.12101 (open access).Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×